Samarth Kulkarni @CrisprSam Twitter profile

Last Seen Profiles

@ludivin_he

@SScoutUSA

@UrQueenPUBG

@MmamaLlama6

@AjourRemi

@bokeplokalmalam

@rainingcrows_

@Crisca97227

@azharsalisa

@CathleenB23

@GDBBS

@kyu_bataoo

@shatiku_b

@u1_nagata

@protus_pr

@vh5ioP0Op4i44eX

@youtv_official

@chune_global

@Verdo76

@NeverGrowUpYo

@Karim_bambaaa

@TheeDrewPittman

@DrawCrazyxd

@dw_russian

@AsupanRemaja5

@ZusiveLande

@UmbrellaCorp_RE

@MotoGP

@65_alqallaf

@elmalibaby

@iamjibbish

@lucky_hafner

@REAL_AHDUDE

@khoacubukkl

@BinorRaja

@Kelia57

Samarth Kulkarni

@CrisprSam

9 months

Historic day! Proud of the CRISPR/Vertex team and grateful to the PIs and patients who helped us get here.

CRISPR Therapeutics

@CRISPRTX

9 months

#Breaking : The U.S. FDA approves the CRISPR/Cas9 gene-edited treatment, co-developed with Vertex Pharmaceuticals, for #SickleCellDisease . Learn more:

22

138

488

23

42

290

Samarth Kulkarni

@CrisprSam

10 months

Momentous day today. Proud of the team and the investigators and patients who were part of the trials. And excited for patients. @CRISPRTX

24

16

208

Samarth Kulkarni

@CrisprSam

7 months

Great to see CRISPR and Casgevy on Jeopardy! Becoming a part of the mainstream consciousness.

11

32

185

Samarth Kulkarni

@CrisprSam

2 years

We have seen unprecedented innovation in biotech in the last 5 years (more than any other prior period). But we need to build real (and disciplined) businesses, not just spew out new platforms. Quality companies will come out even stronger! #innovationthatmatters

8

13

169

Samarth Kulkarni

@CrisprSam

1 year

I’m incredibly proud to share that we have completed the submission of our BLAs for the potential first-ever CRISPR-based therapy! Hope this milestone will be the first of many. Congrats to the team @CRISPRTX @VertexPharma and thanks to our investigators and patients on the trial

CRISPR Therapeutics

@CRISPRTX

1 year

We are pleased to announce that we’ve completed the submission of our Biologics License Applications (BLAs) to the U.S. FDA for our potential treatment for sickle cell disease and beta thalassemia. Learn more:

10

48

228

16

120

Samarth Kulkarni

@CrisprSam

2 years

One of the most exciting weekends for @CRISPRTX at @EHA_Hematology 2022 meeting in Vienna. Remarkable data in Sickle cell and TDT with CTX001, and new hope for patients with T-cell lymphomas with CTX130. Many thanks to the team, our partners, investigators & patients! #EHA2022

16

17

120

Samarth Kulkarni

@CrisprSam

2 years

I’m so proud of our teams for this exciting milestone of completing the first-ever global regulatory submission for a CRISPR-based therapy! This is a historic achievement and thank you to all who have contributed to make this possible. @CRISPRTX $CRSP

CRISPR Therapeutics

@CRISPRTX

2 years

CRISPR Therapeutics and Vertex are pleased to share that we completed our regulatory submissions for exa-cel for sickle cell disease and beta thalassemia in the EU and the UK in December 2022.

7

41

250

12

14

117

Samarth Kulkarni

@CrisprSam

3 years

Biomedical progress continues at an astounding pace. Off-the-shelf organs becoming a reality. @CRISPRTX we are developing off-the-shelf pancreatic islet cells from stem cells for Diabetes $CRSP

Roni Rabin

@RoniNYTimes

3 years

In a first-ever medical breakthrough, an ailing 57-year-old man has gotten a new heart -- from a pig.

21

98

319

11

10

78

Samarth Kulkarni

@CrisprSam

3 years

Thankful for the year we’ve had at CrisprTx. Lot of foundational progress and excited for 2022! I will be out there talking about the progress a lot more after staying relatively low-key this year. HNY!

6

4

67

Samarth Kulkarni

@CrisprSam

4 years

Congratulations to Emmanuelle Charpentier and Jennifer Doudna for winning the 2020 #NobelPrize for #CRISPR . No one more deserving than Emmanuelle and she continues to inspire us everyday @CRISPRTX as we work towards bringing this groundbreaking technology to patients!

7

17

66

Samarth Kulkarni

@CrisprSam

5 years

Proud of the @CRISPRTX / @VertexPharma team today for the progress on CTX001, and thankful for the investigators and patients taking part in this groundbreaking research. A significant landmark, not just for us as a company but for the whole field #hemoglobinopathies #CRISPRCas9

CRISPR Therapeutics

@CRISPRTX

5 years

$CRSP and @VertexPharma announce early positive safety and efficacy data from the first two patients treated with the investigational CRISPR/Cas9 gene-editing therapy CTX001 for severe hemoglobinopathies. Learn more here:

0

50

99

1

18

63

Samarth Kulkarni

@CrisprSam

2 years

Incredible year @CRISPRTX . BLA filing, several clinical trials progressing, 3 new INDs/CTAs, state of the art manufacturing facility and new CRISPR-X group. Patient stories like this one below keep us inspired to do even more!

NPR

@NPR

2 years

Despite rounds of chemotherapy and a stem cell transplant, nothing was working for these two cancer patients. Then, doctors tried something new: the CRISPR gene-editing technique. NPR got exclusive access to tell their stories.

6

49

201

6

4

58

Samarth Kulkarni

@CrisprSam

9 months

My PhD advisor and an amazing mentor. Learned so much from him, not just about science but life in general. Sad day. RIP.

Nicholas A. Peppas

@NPeppas

9 months

A major loss for all of us. Allan Hoffman (1932-2023) Univ_Washington passed away today. Allan was my academic brother (PhD '57 MIT) and great mentor. Devastated. He was such an inspiration to all of us. All in tears after we received the news about an hour ago. RIP.

19

22

167

1

3

60

Samarth Kulkarni

@CrisprSam

4 years

Biotech lab employees are essential workers! We’ve had 190 brave researchers @crisprtx come into the lab every day for the last year to bring medicines to patients....we need to get them vaccines! @MassBio @MassGovernor

3

53

Samarth Kulkarni

@CrisprSam

6 years

6 years since the Charpentier/Jinek publication elucidating CRISPR/Cas9 for gene editing...so much progress in such a short amount of time! CRISPR is going to continue to move much faster than previous tech disruptions...

1

9

45

Samarth Kulkarni

@CrisprSam

4 years

Thank you @adamfeuerstein & bio-verse! Surprised to even be nominated given CRISPR is still in its early stages of growth. The vote of confidence is likely a reflection of the potential of the platform & the wonderful team @CRISPRTX , whom I have the joy of working with every day!

3

1

45

Samarth Kulkarni

@CrisprSam

3 years

Proud of the team at CRISPR for achieving another incredible milestone!

CRISPR Therapeutics

@CRISPRTX

3 years

We are pleased to announce that the U.S. FDA has granted Regenerative Medicine Advanced Therapy (RMAT) designation to CTX110™ for the treatment of relapsed or refractory CD19+ B-cell malignancies. Learn more here:

2

26

101

6

0

43

Samarth Kulkarni

@CrisprSam

2 years

Incredibly proud of the team @CRISPRTX . This is as State-of-the-Art as it gets for cell therapies!

CRISPR Therapeutics

@CRISPRTX

2 years

We are honored to receive the Facility of the Year Award ( #FOYA ) in Innovation from the International Society for Pharmaceutical Engineering ( @ISPEorg ) for our flexible, digitally-enabled manufacturing facility in Framingham, MA. Learn more here:

0

7

31

5

1

39

Samarth Kulkarni

@CrisprSam

4 years

Enjoyed my fireside chat with @hannahkuchler this morning on #FTPharma . CRISPR as a technology is not just going to transform medicine as we know it today, it is going to completely change the business model for Biopharma companies @CRISPRTX #CURES

0

7

34

Samarth Kulkarni

@CrisprSam

4 years

One powerful way to begin correcting the inequities of the past - #CureSickleCell #SickleCellDisease #SickleCellAwareness A Year In, 1st Patient To Get Gene-Editing For Sickle Cell Disease Is Thriving

0

13

33

Samarth Kulkarni

@CrisprSam

3 years

Enjoyed being on the @blackrock The Bid podcast to discuss Covid-19 and the future of medicine!

CRISPR Therapeutics

@CRISPRTX

3 years

Thank you @BlackRock for having $CRSP CEO @CrisprSam on The Bid podcast to discuss how we have advanced clinical trials for CRISPR-based medicines to treat serious diseases including #SickleCell , #BetaThalassemia and cancer.

2

11

55

1

32

Samarth Kulkarni

@CrisprSam

4 years

We are excited to bolster our manufacturing capabilities and competency! Thanks to @MassGovernor and his team for the encouragement and support. @CRISPRTX

CRISPR Therapeutics

@CRISPRTX

4 years

Today $CRSP announced that we are building a new cell therapy manufacturing facility in Framingham, Massachusetts for clinical and commercial production of our investigational cell therapy product candidates. Learn more here:

0

17

45

3

1

30

Samarth Kulkarni

@CrisprSam

2 years

Enjoyed being on the @NasdaqExchange with @aurmanARK discussing allogeneic CAR-Ts @CRISPRTX and how they can have global impact in treating cancers!

Nasdaq Exchange

@NasdaqExchange

2 years

"We're very passionate about bringing these therapies to patients around the world." @CRISPRTX CEO @CrisprSam discusses how advancements in cell and gene therapy innovation will shape the future of medicine across the globe. Learn more:

1

2

14

1

4

28

Samarth Kulkarni

@CrisprSam

1 year

Exciting day at #EBMT23 for @CRISPRTX . Two Presidential symposia talks - one on Exa-cel by Dr. Locatelli and one on CTX110 by Dr. McGuirk. Kudos to the team and thanks to our investigators

2

4

31

Samarth Kulkarni

@CrisprSam

3 years

Excited to begin clinical trials with gene edited smart cells for patients with diabetes!

CRISPR Therapeutics

@CRISPRTX

3 years

Today, @CRISPRTX and @ViaCyte announced the approval of our Clinical Trial Application (CTA) for type 1 diabetes (T1D). Read more here:

3

36

164

2

29

Samarth Kulkarni

@CrisprSam

2 years

As we get into proxy season, let's begin the annual charade of @issesg ISS and Glass Lewis @GlassLewis ratings, just so companies can hire them to "fix" ESG issues. Apparently developing curative medicine does not qualify as social good per these ratings agencies

3

28

Samarth Kulkarni

@CrisprSam

4 years

@CRISPRTX We capped off an exciting week beginning with our ASH presentation in #Sicklecell and #Thalassemia with a company townhall featuring our scientific founder Emmanuelle Charpentier! @manue_lab . It was great to hear from her (& see what the prize actually looks like)!

0

1

29

Samarth Kulkarni

@CrisprSam

3 years

I am so proud of this recognition (this survey was completely outside-in)! I am honored to be leading such a wonderful group of people, all dedicated to the cause of making transformative medicines! @CRISPRTX

CRISPR Therapeutics

@CRISPRTX

3 years

We’re proud to be recognized as the #1 employer in @biospace 's 2022 #BestPlacestoWork report, among top biopharma employers with <1,000 employees. This survey spotlights companies that life sciences professionals consider top choice employers. Read more:

0

5

44

1

0

26

Samarth Kulkarni

@CrisprSam

2 years

Enjoyed this podcast recording with @chadinabhan ! Straight talk on various efforts ongoing @CRISPRTX and the evolution of medicine. $CRSP #HealthcareUnfiltered

chadi nabhan MD, MBA, FACP

@chadinabhan

2 years

Newest #HealthcareUnfiltered is out with @CrisprSam CEO of @CRISPRTX breaking down the #Healthcare technology of the future. In celebrating research advances at @AACR , listen to Sam an inspiring scientist leader focused on patients & people. Must listen.

0

5

14

1

2

25

Samarth Kulkarni

@CrisprSam

4 years

Exciting day for us @crisprtx and our partners @VertexPharma with our data presentation at #EHA25 . We are grateful to our investigators and patients in the study and proud of the team in getting to this milestone.

CRISPR Therapeutics

@CRISPRTX

4 years

#Breaking : Today, $CRSP and @VertexPharma announced new clinical data and progress for CTX001™ in severe hemoglobinopathies at the #EHA25Virtual Congress. Learn more here:

1

14

47

3

1

23

Samarth Kulkarni

@CrisprSam

3 years

@CRISPRTX , we are re-imagining how we think about medicine! Off-the-shelf pancreas to treat Diabetes (together with our partner @ViaCyte )

CRISPR Therapeutics

@CRISPRTX

3 years

Today, @CRISPRTX and @ViaCyte announced that the first patient has been dosed in the Phase 1 clinical trial of VCTX210 for the treatment of type 1 diabetes (T1D). Read more here:

10

42

165

3

1

22

Samarth Kulkarni

@CrisprSam

5 years

Kudos to our in vivo team! We are going to keep charging ahead with both ex vivo and in vivo gene editing approaches in a number of different indications. Also pleased to strengthen partnership with Vertex @CRISPRTX $CRSP $VRTX @VertexPharma

CRISPR Therapeutics

@CRISPRTX

5 years

We’re excited to expand our collaboration with @VertexPharma to develop best-in-class gene-edited therapies for Duchenne Muscular Dystrophy and Myotonic Dystrophy Type 1. Learn more here: $CRSP

1

16

45

0

2

20

Samarth Kulkarni

@CrisprSam

7 years

Momentous occasion for our company! Proud of the team $CRSP

CRISPR Therapeutics

@CRISPRTX

7 years

$CRSP submits first clinical trial application in Europe for a CRISPR-based therapy in beta-thalassemia

2

34

48

1

6

20

Samarth Kulkarni

@CrisprSam

5 years

My main job when I’m at home in India - IT support for my parents :) Can’t believe how many Apple devices they own. And oh btw, iOS13 sucks.

1

0

20

Samarth Kulkarni

@CrisprSam

5 years

What will 2020 bring for medicine and science? - STAT. Excited for what CRISPR will bring and other advances in diagnostics, digital health and most importantly, global public health!

What will 2020 bring for medicine and science? We asked 16 leaders for predictions

What will 2020 bring for medicine and science? We asked 16 leaders for predictions.

www.statnews.com

0

5

18

Samarth Kulkarni

@CrisprSam

2 years

Very excited to welcome @AlexHarding7 to the @CRISPRTX leadership team!

Alex Harding

@AlexHarding7

2 years

It’s hard to articulate how excited I am to be joining @CRISPRTX . I’m looking forward to learning from everyone on the team and hoping to contribute meaningfully to the company’s work.

13

2

177

1

0

20

Samarth Kulkarni

@CrisprSam

2 years

Looking forward to this panel tomorrow. I’m passionate about bringing CAR-T’s to patients globally!

USAIC

@USAIC

2 years

Last chance to register: #USAIC22 (June 24; digital). Don't miss oncology plenary moderated by Alise Reicin of @TectonicTx w/Christine Ward of @TakedaOncology @EricHRubin @CrisprSam Todd Golub of @broadinstitute & Sam Waksal of @eqbiopharma . Free reg:

0

3

2

0

20

Samarth Kulkarni

@CrisprSam

6 years

Was a privilege to be at the Vatican speaking about gene editing

The Cura Foundation

@CuraFdn

6 years

John Leonard @intelliatweets , George M. Church, and @sam_s_kulkarni discuss how the #UniteToCure conference brings different disciplines together to consider significant medical advances.

0

5

10

0

2

18

Samarth Kulkarni

@CrisprSam

5 years

Great trip to Riyadh. Spoke at #FII2019 and visited King Faisal hospital with Drs. Alshanqeeti, Alzahrani and Ahmed, a leading site for Sickle cell and Cancer care in Asia. Nearly 60k suffer from Sickle cell disease in KSA @FIIKSA

0

1

20

Samarth Kulkarni

@CrisprSam

4 years

Based on our experience with the RMAT and CTX130 IND, I want to thank and compliment the FDA for their proactive leadership and support in the middle of this pandemic @US_FDA

CRISPR Therapeutics

@CRISPRTX

4 years

We are pleased to announce that CTX001™ has been granted Regenerative Medicine Advanced Therapy (RMAT) designation by the U.S. FDA for the treatment of severe hemoglobinopathies. Learn more here:

0

25

70

0

2

18

Samarth Kulkarni

@CrisprSam

4 years

Excited to have Philippe on board as our CCO in this next phase of growth for our company @CRISPRTx $CRSP !

CRISPR Therapeutics

@CRISPRTX

4 years

We’re pleased to announce that Philippe Drouet has joined $CRSP as Chief Commercial Officer. Read more about his appointment here:

6

58

1

16

Samarth Kulkarni

@CrisprSam

6 years

Proud of the intrepid CRISPR I/O team presenting 6-plex (!!) editing at #SITC18 @CRISPRTX Range of outfits as diverse as our company :)

1

17

Samarth Kulkarni

@CrisprSam

2 years

Incredibly excited to have Maria on board to help build a great company and bring cures to patients! $CRSP @CRISPRTX #ReimagineMedicine

CRISPR Therapeutics

@CRISPRTX

2 years

We are pleased to invite Maria Fardis Ph.D., MBA to join our Board of Directors. Her extensive leadership in scaling companies and bringing novel therapies to patients will be invaluable as we continue to advance our pipeline and platform. Learn more here:

0

5

27

1

17

Samarth Kulkarni

@CrisprSam

1 year

Happy to be a sponsor for the #NAACPConvention in Boston. We are proud to be developing a medicine @CRISPRTX for Sickle cell - a disease that has been ignored for far too long

2

17

Samarth Kulkarni

@CrisprSam

7 years

Humbled and honored to be asked to lead $crsp in its next phase. Thanks to Rodger Novak for his exemplary leadership over the last 4 years

6

2

17

Samarth Kulkarni

@CrisprSam

2 years

Very excited to have P.K. join us as Chief Medical Officer @CRISPRTX !!

CRISPR Therapeutics

@CRISPRTX

2 years

We’re pleased to announce that Dr. Phuong Khanh (P.K.) Morrow, M.D., FACP, is joining us as Chief Medical Officer. Read more about her appointment here:

1

3

30

1

0

17

Samarth Kulkarni

@CrisprSam

5 years

Enjoyed the ARM panel discussion today on cell therapies in cancer. 2020 promises to be an important year for allogeneic therapies

Alliance for Regenerative Medicine (ARM)

@alliancerm

5 years

@Sam_S_Kulkarni , CEO at @CRISPRTX says, “We’re now entering an age of cell therapies. [...] in the next 5-6 years,” says that 1/3 of the market for liquid tumors will be in cell therapies. #JPMWeek #JPM20 #JPM2020 #celltherapy #CARTcell #SOTI20

0

2

17

Samarth Kulkarni

@CrisprSam

3 years

Economists are missing the fact that inflation is bimodal right now. Traditional measures don’t reflect reality. We should all be giving/donating these holidays!

2

0

16

Samarth Kulkarni

@CrisprSam

6 years

Proud to have Ewelina present on CRISPR-based CAR-T at #IKCS18 @CRISPRTX

Fabio Schutz

@FabioSchutz78

6 years

Outstanding talk by Dr. Ewelina Morawa about CAR-T and CRISPR technology and its potential use in RCC therapy. Challenges in solid tumors. CD70 seems a good target in solid tumors and RCC. CTX130 to go to clinical trials. #IKCS18

0

4

15

0

5

15

Samarth Kulkarni

@CrisprSam

6 years

Beautiful summer day in Zurich as we start our Board mtg. On tap: the changing nature of competition in the biotech world...

0

15

Samarth Kulkarni

@CrisprSam

5 years

Really enjoyed the panel discussion with @matthewherper and my fellow panelists #CRISPR $CRSP

Matthew Herper

@matthewherper

5 years

If you're a @statnews subscriber, watch video from last night's event on #CRISPR here! Featuring $CRS, $NTLA, $EDIT, Beam, KSQ and Synthego, plus Jeantine Lunshof and an amazing audience!

0

1

14

0

5

14

Samarth Kulkarni

@CrisprSam

5 years

Thoroughly enjoyed the USAIC conf - one of the best meetings on a host of biopharma industry topics #usaic2019 . Enjoyed having Jim Wilson, Dan Curran, David Lucchino, Dhaval Patel and Tim Yu on the Rare diseases panel that I moderated.

0

2

14

Samarth Kulkarni

@CrisprSam

3 years

Kudos to the @RepareRx team - synthetic lethality coming of age!

Lloyd M. Segal

@LM_Segal

3 years

Huge leap forward for @RepareRx , our clinical collaborators and, above all, the #patients whose lives we aspire to positively impact, our 2nd #targetedtherapy now in the clinic. Kudos to the amazing team and clinical collaborators! #precisiononcology #syntheticlethality

0

16

3

1

13

Samarth Kulkarni

@CrisprSam

4 years

Congrats to the biopharma heroes of the year – Stephane, Albert, Ugur and others – who have achieved the impossible through sheer grit and determination. And much respect to Behzad, Tassos and other biotech CEOs for making 2020 such a productive year for the industry.

0

14

Samarth Kulkarni

@CrisprSam

6 years

So proud of the team @CRISPRTX $CRSP Progress on all fronts

CRISPR Therapeutics and Vertex Announce Progress in Clinical Development Programs for the Investi...

-First patient infused with CTX001 in a Phase 1/2 clinical trial for patients with beta thalassemia- -First patient enrolled in a Phase 1/2 clinical trial...

www.globenewswire.com

0

2

14

Samarth Kulkarni

@CrisprSam

1 year

Excited to have Raju @rprasad5 on board @CRISPRTX . Welcome to the management team!

CRISPR Therapeutics

@CRISPRTX

1 year

We’re excited to welcome Raju Prasad, Ph.D., as Chief Financial Officer of @CRISPRTX . Dr. Prasad brings in-depth knowledge of the cell and gene therapy space along with extensive experience in capital markets. Learn more:

0

9

43

1

2

14

Samarth Kulkarni

@CrisprSam

5 years

Amazing plenary by our own Ewelina Morawa at #AACR19 on Allo-CART and great job by our research teams on our poster presentations @CRISPRTX $CRSP

1

7

13

Samarth Kulkarni

@CrisprSam

6 years

Excited about the caliber of leaders we have been able to bring in over the last few months - John Leonard as head of in vivo, John Martin who was top official at the FDA and Julian Fowler to transform digital for us! $CRSP @CRISPRTX

CRISPR Therapeutics

@CRISPRTX

6 years

We are pleased to welcome John Martin as Head of Government Affairs, and Julian Fowler as Head of IT at CRISPR Therapeutics! John and Julian bring unique expertise to our expanding leadership team and company during this phase of our growth.

0

1

9

0

13

Samarth Kulkarni

@CrisprSam

6 years

Apropos for my 100th tweet....Congrats to Emmanuelle and Jennifer for receiving the 2018 Kavli Prize @KavliPrize #CRISPR

Jennifer Doudna shares 2018 Kavli Prize in Nanoscience - Berkeley News

Doudna and her colleague Emmanuelle Charpentier, who together invented the CRISPR-Cas9 gene editing tool, shared the prize with Lithuanian biologist Virginijus Šikšnys, who simultaneously discovered...

news.berkeley.edu

0

4

12

Samarth Kulkarni

@CrisprSam

5 years

This is a disease that has been ignored for too long....we are 100% committed to Sickle cell disease and hope that our efforts bring a transformative cure for these patients....

CRISPR Therapeutics

@CRISPRTX

5 years

On this #WorldSickleCellDay , we’re standing behind the people living with #sicklecell disease and their caregivers. We’re proud to work with @VertexPharma to advance new treatment options for those living with this devastating disease. #WSCD2019

0

10

26

0

1

12

Samarth Kulkarni

@CrisprSam

6 years

The women at CRISPR are doing amazing things on all fronts. And their courage and dedication is a huge inspiration for me!

CRISPR Therapeutics

@CRISPRTX

6 years

For International Women's Day, we're celebrating the amazing women in our lives. Who inspires you? #IWD2019 #BalanceForBetter

0

3

11

0

2

12

Samarth Kulkarni

@CrisprSam

2 years

ISS will give companies a bad rating and then sell their consulting services to the company to “help” improve the ratings.

Vivek Ramaswamy

@VivekGRamaswamy

2 years

I’ve traveled the country to meet with state pension funds, treasurers, and corporations. It is *staggering* how much influence BlackRock & ISS have wielded over these institutions. They captured the system in red & blue states alike. Time to bring new alternatives to the table.

157

1K

5K

0

1

10

Samarth Kulkarni

@CrisprSam

6 years

JPM’s too crowded....no one goes there anymore...

0

11

Samarth Kulkarni

@CrisprSam

7 years

Excited to continue to work closely with our partner Vertex on CTX001! $CRSP $vrtx

CRISPR Therapeutics

@CRISPRTX

7 years

Today @VertexPharma opted in to co-develop and co-commercialize CTX001, an investigational gene-editing treatment. $CRSP is excited to partner with $VRTX to develop a potentially transformative therapy for sickle cell disease and beta thalassemia

1

12

20

0

2

11

Samarth Kulkarni

@CrisprSam

5 years

I am glad world leaders are starting to take wildlife and nature conservation seriously.

Bear Grylls OBE

@BearGrylls

5 years

People across 180 countries will get to see the unknown side of PM @narendramodi as he ventures into Indian wilderness to create awareness about animal conservation & environmental change. Catch Man Vs Wild with PM Modi @DiscoveryIN on August 12 @ 9 pm. #PMModionDiscovery

6K

37K

109K

1

0

11

Samarth Kulkarni

@CrisprSam

6 years

So proud of the team! #stompoutsickle

CRISPR Therapeutics

@CRISPRTX

6 years

Team @CRISPRTX is proud to join the Greater Boston Sickle Cell Disease Association and local community to help #stompoutsickle

1

14

1

0

9

Samarth Kulkarni

@CrisprSam

6 years

CRISPR technology can unleash the power of regenerative medicine!

CRISPR Therapeutics

@CRISPRTX

6 years

$CRSP and ViaCyte announce strategic collaboration to develop gene-edited stem cell-derived therapy for diabetes, accelerating CRISPR's efforts in regenerative medicine. Learn more here

0

10

35

1

3

8

Samarth Kulkarni

@CrisprSam

5 years

Enjoyed the discussion at the Financial Times @FTLiveHealth summit and panel today...

CRISPR Therapeutics

@CRISPRTX

5 years

Many thanks to @FTLiveHealth for including our own @Sam_S_Kulkarni in a discussion today about delivering on the potential of advanced cell and gene therapies at the FT US Pharma and Biotech Summit. #FTUSPharma

0

1

22

1

0

9

Samarth Kulkarni

@CrisprSam

8 years

Last week we reached 100 employees at CRISPR Therapeutics! Exciting journey @CRISPRTX #CRISPR

0

2

9

Samarth Kulkarni

@CrisprSam

8 years

Pleased to have Jeff Leiden and George Daley as honorary guests for our grand opening of CRISPR Tx's new location at 610 Main St. #CRISPRTx

0

5

7

Samarth Kulkarni

@CrisprSam

7 years

Judging by the press coverage today, base editing is definitely more exciting than base jumping...

0

8

Samarth Kulkarni

@CrisprSam

4 years

Congrats to our partner, ViaCyte, on this update and fund-raise! We are excited about our collaboration @ViaCyte @CRISPRTX

0

1

8

Samarth Kulkarni

@CrisprSam

7 years

Excited to welcome Mike on board! $CRSP

CRISPR Therapeutics

@CRISPRTX

7 years

$CRSP announces appointment of Michael Tomsicek as Chief Financial Officer

0

2

3

0

8

Samarth Kulkarni

@CrisprSam

4 years

@BTLipschultz You are fast, Bailey @BTLipschultz ! We are excited to start trials with our CAR-Ts in solid tumors - new frontier.

0

7

Samarth Kulkarni

@CrisprSam

6 years

Congrats to our partner ViaCyte @ViaCyte for the nice fund raise, which will accelerate transformative therapies for diabetes patients @CRISPRTX

0

1

6

Samarth Kulkarni

@CrisprSam

7 years

Distributed innovation with CRISPR is going to be the basis of a competitive advantage over other platforms. Publications from both coasts today on CRISPR for hearing loss and ALS

0

1

5

Samarth Kulkarni

@CrisprSam

5 years

I’m 89% sure it will work 100% all the time

Jonathan Wilde

@circuit_logic

5 years

Okay, here are my prime editing takes. I'm mostly going to try to be a voice of reason here. Not because I'm hyper critical of the paper but because it's necessary. This field is full of mega hype and cool tech, but cool doesn't get us anywhere unless it works as advertised.

16

268

705

1

0

5

Samarth Kulkarni

@CrisprSam

7 years

Excited to be partnering with Aravind Asokan and team to develop new AAV vectors $CRSP @casebiatx

0

1

5

Samarth Kulkarni

@CrisprSam

4 years

Exciting partnership between Repare Tx and BMS on CRISPR-based synthetic lethality to fight various cancers. ⁦⁦ @reparetx ⁩

Repare Therapeutics Announces Multi-Target Discovery Collaboration with Bristol Myers Squibb

Repare Therapeutics Inc. (“Repare”), a precision oncology company pioneering synthetic lethality to develop novel therapeutics that target specific vu

www.businesswire.com

0

5

Samarth Kulkarni

@CrisprSam

5 years

Great work in the community by @LS_Cares and @robperez32 . Glad @CRISPRTX can be part of it!

CRISPR Therapeutics

@CRISPRTX

5 years

@CRISPRTX is proud to be a founding member of the inspiring @LS_Cares ! We were honored to join over 500 others in the Biotech community at the 2019 Impact Breakfast. We look forward to continued partnership to make a difference in the greater Boston community. #LSCImpact

0

5

8

0

5

Samarth Kulkarni

@CrisprSam

7 years

Looking forward to working with Marcela on next gen T-cell therapies @MausMarcela $CRSP @CRISPRTX

John Carroll

@JohnCendpts

7 years

Building up its I/O ops, CRISPR Therapeutics allies with Marcela Maus at Mass General $CRSP

0

4

0

5

Samarth Kulkarni

@CrisprSam

7 years

Great article. We are standing on the shoulders of giants in our efforts at CRISPR Tx in tackling Sickle cell disease

Nature - A tour through the most studied genes in biology reveals some surprises.

www.nature.com

0

1

5

Samarth Kulkarni

@CrisprSam

5 years

RIP. Amazing inventor - I remember interacting with him while in grad school when I was making Taq variants!

BioCentury

@BioCentury

5 years

Kary Mullis, PCR inventor, passes at age 74

2

4

3

0

4

Samarth Kulkarni

@CrisprSam

7 years

Proud of our CRISPR Tx I/O team for presenting a terrific poster at #SITC2017 $CRSP

0

2

4

Samarth Kulkarni

@CrisprSam

5 years

Great to be a part of these impactful initiatives by @LS_Cares and @c2cboston . And proud of the @CRISPRTX team! @robperez32

CRISPR Therapeutics

@CRISPRTX

5 years

We were thrilled to host our 2019 Volunteer Day this week in partnership with @LS_Cares and @c2cboston , making over 80 blankets, 40 Happy Hope Bags and sorting donated clothing, impacting over 1,000 children in the Greater Boston area. Thanks to all of our employees!

0

2

10

0

4

Samarth Kulkarni

@CrisprSam

6 years

"Unite to Cure": Scientists, Patients Preach Medical Progress at the Vatican

Scientists and patients preach medical progress at “Unite to Cure”, held at the Vatican.

www.genengnews.com

0

4

Samarth Kulkarni

@CrisprSam

8 years

CRISPR now in Merriam-Webster's

0

3

Samarth Kulkarni

@CrisprSam

7 years

Great thought leadership on future of CRISPR from our Scientific founder, Matt Porteus @Stanford at the Senate HELP committee hearing today $CRSP #CRISPR

0

1

3

Samarth Kulkarni

@CrisprSam

4 years

Congrats to my friend Jacob on launching this important study @sands_jacob

Jacob sands

@sands_jacob

4 years

A lot of work by a lot of people led to opening this lung cancer adjuvant study. 3-arm randomization to SOC chemo vs SEQUENTIAL chemo/pembro vs CONCURRENT chemo/pembro. Now open!

0

3

23

0

3

Samarth Kulkarni

@CrisprSam

6 years

Insightful chart. This is why we need to move allogeneic CAR-T’s as expeditiously as possible into the clinic! #ASH18 @CRISPRTX

0

1

2

Samarth Kulkarni

@CrisprSam

4 years

@SCClemons @CRISPRTX Enjoyed the discussion @SCClemons ! Terrific virtual conference touching upon all the critical and relevant issues in healthcare #TheHillHealth @CRISPRTX

0

3

Samarth Kulkarni

@CrisprSam

7 years

Proud of Nav Singh @Nav_Imagine for his accomplishments as Chairman of the Boston Chamber of Commerce @McKinsey @bostonchamber

0

3

Samarth Kulkarni

@CrisprSam

7 years

Excited to have Tony Ho on board @CRISPRTx to lead our R&D through the next phase of growth! $CRSP

CRISPR Therapeutics

@CRISPRTX

7 years

$CRSP announces appointment of Tony W. Ho as Head of Research & Development

0

4

6

0

1

3

Samarth Kulkarni

@CrisprSam

5 years

@natsturner No kidding. Some GMs are probably feeling very stupid right now!

1

0

2

Samarth Kulkarni

@CrisprSam

7 years

mRNA critical piece of the solution for in vivo programs. Excited to partner with CureVac on this!

CRISPR Therapeutics

@CRISPRTX

7 years

$CRSP and @casebiatx collaborate with CureVac on novel Cas9 mRNA constructs for gene-editing programs

0

8

13

0

2

Samarth Kulkarni

@CrisprSam

8 years

Early start to JPM this year. At the Eastwestceo conf #JPM17

2

1

Samarth Kulkarni

@CrisprSam

6 years

@robperez32 @CRISPRTX @LS_Cares Huge honor to host @robperez32 yesterday to celebrate the 5th anniversary of @CRISPRTX ! Terrific insights on building a great company..and keeping a relentless focus on our true north - curing patients!

0

1

2

Samarth Kulkarni

@CrisprSam

5 years

Really sad...we need to take animal conservation more seriously

CITES

@CITES

5 years

Sad news! The Sumatran #rhino – the world’s smallest rhino – has become extinct in Malaysia after the last surviving individual died in captivity #RacingExtinction

19

325

267

1

0

2

Samarth Kulkarni

@CrisprSam

8 years

Real question is - what age did they make their major breakthroughs?